How Non-Vegans Lift Beyond Meat Stock
Beyond Meat aims to expand in U.S. supermarkets and restaurants and is looking beyond vegans and vegetarians.
Beyond Meat aims to expand in U.S. supermarkets and restaurants and is looking beyond vegans and vegetarians.
Sometimes the best way to get a message out is visually. After all, there is an absolute media overload that occurs for many people who invest and for those who just watch the news.…
While Amazon has been growing and taking over certain aspects of the U.S. economy, Shopify has been growing exponentially and taking its share of the e-commerce pie. Facebook wants its slice of the action…
The euphoria that followed the announcement Wednesday that Aurora Cannabis is acquiring Reliva was subsiding Friday.
Beyond Meat’s stock has had a huge rally but the company needs new sales channels and price parity with traditional meat.
Altria wants to diversify into e-cigarettes and legal pot, but faces regulatory action, patent litigation and coronavirus-related setbacks.
Aphria stays strong while Green Growth, which tried to buy it, goes bust. Canadian rival Aurora buys U.S. hemp retailer Reliva.
Investors can’t figure out if it’s dawn or dusk for Aurora Cannabis, and that means a wild ride for the stock.
High times in hard times? Tilray says pot should be seen as a consumer staple rather than an indulgence.
U.K. tobacco giant Imperial Brands has slashed its dividend. Will American tobacco companies follow suit?
As the pandemic impacts meat-processing capacity, investors might have an appetite for alternatives such as Beyond Meat.
Nike looks fairly fit as stores start to reopen, online sales surge, and health-minded consumers look to more active lifestyles.
Altria's share price is falling. Its investments have been busts, and hedge funds and shareholders are getting cranky. Even the dividend hasn't made investors happy.
Altria’s investments in Juul and Cronos Group weigh on investor sentiment even though core tobacco business looks strong.
Canadian pot company Aphria is well positioned in the medical and recreational sectors. It has eyes on Europe but the coronavirus has stalled legalization efforts in the U.S.